E-LIB Suche - Ergebnisse für: Shukarev, Georgi

1

Safety and Immunogenicity of an Accelerated Ebola Vaccinati..:

Ake, Julie A. ; Paolino, Kristopher ; Hutter, Jack N....
Vaccines. 12 (2024) 5 - p. 497 , 2024

Link: https://doi.org/10.3390/..

2

Safety and Immunogenicity of Accelerated Heterologous Two-d..:

Mwesigwa, Betty ; Sawe, Fredrick ; Oyieko, Janet...
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

3

Thrombosis with thrombocytopenia syndrome: A database revie..:

Struyf, Frank ; Hardt, Karin ; Van Rampelbergh, Rian...
Vaccine. 41 (2023) 37 - p. 5351-5359 , 2023

Link: https://doi.org/10.1016/..

4

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV..:

Anywaine, Zacchaeus ; Barry, Houreratou ; Anzala, Omu...
PLOS Medicine. 19 (2022) 1 - p. e1003865 , 2022

Link: https://doi.org/10.1371/..

5

Durable antibody responses elicited by 1 dose of Ad26.COV2...:

Sadoff, Jerald ; Le Gars, Mathieu ; Brandenburg, Boerries...
Vaccine. 40 (2022) 32 - p. 4403-4411 , 2022

Link: https://doi.org/10.1016/..

6

First-in-human study to evaluate safety, tolerability, and ..:

Bockstal, Viki ; Shukarev, Georgi ; McLean, Chelsea...
PLOS ONE. 17 (2022) 10 - p. e0274906 , 2022

Link: https://doi.org/10.1371/..

7

Safety and immunogenicity of 3 formulations of a Sabin inac..:

Ong-Lim, Anna Lisa ; Shukarev, Georgi ; Trinidad-Aseron, Mitzi...
Human Vaccines & Immunotherapeutics. 18 (2022) 5 - p. , 2022

Link: https://doi.org/10.1080/..

8

Quantifying Antibody Persistence After a Single Dose of COV..:

Dari, Anna ; Boulton, Muriel ; Neyens, Martine...
Clinical Pharmacology & Therapeutics. 113 (2022) 2 - p. 380-389 , 2022

Link: https://doi.org/10.1002/..

9

Vaccines based on replication incompetent Ad26 viral vector..:

Custers, Jerome ; Kim, Denny ; Leyssen, Maarten...
Vaccine. 39 (2021) 22 - p. 3081-3101 , 2021

Link: https://doi.org/10.1016/..

10

Assessments of different batches and dose levels of a two-d..:

Bockstal, Viki ; Gaddah, Auguste ; Goldstein, Neil...
npj Vaccines. 6 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

11

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV..:

Barry, Houreratou ; Mutua, Gaudensia ; Kibuuka, Hannah...
PLOS Medicine. 18 (2021) 10 - p. e1003813 , 2021

Link: https://doi.org/10.1371/..

12

1049. Minimal Transient HIV-1 Viremia Following Vaccination..:

Custer, Benjamin L ; Mwesigwa, Betty ; Sawe, Fredrick...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S616-S616 , 2021

Link: https://doi.org/10.1093/..

13

LB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SA..:

Le Gars, Mathieu ; Sadoff, Jerald ; Jongeneelen, Mandy...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S804-S805 , 2021

Link: https://doi.org/10.1093/..

14

Ebola virus glycoprotein stimulates IL-18–dependent natural..:

Wagstaffe, Helen R. ; Clutterbuck, Elizabeth A. ; Bockstal, Viki...
Journal of Clinical Investigation. 130 (2020) 7 - p. 3936-3946 , 2020

Link: https://doi.org/10.1172/..

15

Safety and immunogenicity of a new Sabin inactivated poliov..:

Leroux-Roels, Isabel ; Leroux-Roels, Geert ; Shukarev, Georgi...
Human Vaccines & Immunotherapeutics. 17 (2020) 5 - p. 1366-1373 , 2020

Link: https://doi.org/10.1080/..